The organic chemistry of drug design and drug action / (Record no. 15920)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01560nam a2200253Ia 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | NULRC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250520102818.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 250520s9999 xx 000 0 und d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780123820303 |
040 ## - CATALOGING SOURCE | |
Transcribing agency | NULRC |
050 ## - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RS 403 .S55 2014 |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | Silverman, Richard B. |
Relator term | author |
245 #4 - TITLE STATEMENT | |
Title | The organic chemistry of drug design and drug action / |
Statement of responsibility, etc. | Richard B. Silverman and Mark W. Holladay |
250 ## - EDITION STATEMENT | |
Edition statement | Third edition. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | San Diego, California : |
Name of publisher, distributor, etc. | Academic Press, |
Date of publication, distribution, etc. | c2014 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | xvii, 517 pages : |
Other physical details | color illustrations ; |
Dimensions | 29 cm. |
365 ## - TRADE PRICE | |
Price amount | USD58.98 |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc. note | Includes index. |
505 ## - FORMATTED CONTENTS NOTE | |
Formatted contents note | Introduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | The Organic chemistry of drug design and drug action, Third edition, represents a unique approach to medicinal chemistry based on physical organic chemical principles and reaction mechanisms that rationalize drug action, which allows the reader to extrapolate those core principles and mechanisms to many related classes of drug molecules. This new edition reflects significant changes in the process of drug design over the last decade. It preserves the successful approach of the previous editions while including significant changes in format and coverage. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | PHARMACEUTICAL CHEMISTRY |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Holladay, Mark W. |
Relator term | co-author |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Library of Congress Classification |
Koha item type | Books |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Source of acquisition | Cost, normal purchase price | Total checkouts | Full call number | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Library of Congress Classification | Pharmacy | LRC - Main | National University - Manila | General Circulation | 06/14/2017 | Purchased - Amazon | 58.98 | GC RS 403 .S55 2014 | NULIB000013679 | 05/20/2025 | c.1 | 05/20/2025 | Books |